| Schedule (route) | Endpoint | Vehicle | Dose | Treated/Control (%) | Observations |
|---|---|---|---|---|---|
| Q01DX011 (ip) | median survival time | other | 5.0 mg/kg/injection | 111.0 | Antitumor endpoint evaluated on day 45; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX011 (ip) | median survival time | other | 10.0 mg/kg/injection | 88.0 | Antitumor endpoint evaluated on day 45; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX011 (ip) | median survival time | other | 20.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 45; 05/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX011 (ip) | median survival time | other | 40.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 45; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX011 (ip) | mean tumor weight | other | 5.0 mg/kg/injection | 62.0 | Antitumor endpoint evaluated on day 12; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX011 (ip) | mean tumor weight | other | 10.0 mg/kg/injection | 94.0 | Antitumor endpoint evaluated on day 12; 07/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX011 (ip) | mean tumor weight | other | 20.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 12; 05/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX011 (ip) | mean tumor weight | other | 40.0 mg/kg/injection | 49.0 | Antitumor endpoint evaluated on day 12; 08/08 animals surviving on tox evaluation day (usually day 5) |